Abstract |
We have demonstrated that R(+)WIN55,212-2, a synthetic cannabinoid that possesses cannabimimetic properties, acts as a novel regulator of Toll-like receptor 3 (TLR3) signaling to interferon ( IFN) regulatory factor 3 (IRF3) activation and IFN-β expression, and this is critical for manifesting its protective effects in a murine multiple sclerosis model. Here we investigated the role of peroxisome proliferator-activated receptor-α (PPARα) in mediating the effects of R(+)WIN55,212-2 on this pathway. Data herein demonstrate that the TLR3 agonist poly(I:C) promotes IFN-β expression and R(+)WIN55,212-2 enhances TLR3-induced IFN-β expression in a stereoselective manner via PPARα. R(+)WIN55,212-2 promotes increased transactivation and expression of PPARα. Using the PPARα antagonist GW6471, we demonstrate that R(+)WIN55,212-2 acts via PPARα to activate JNK, activator protein-1, and positive regulatory domain IV to transcriptionally regulate the IFN-β promoter. Furthermore, GW6471 ameliorated the protective effects of R(+)WIN55,212-2 during the initial phase of experimental autoimmune encephalomyelitis. Overall, these findings define PPARα as an important mediator in manifesting the effects of R(+)WIN55,212-2 on the signaling cascade regulating IFN-β expression. The study adds to our molecular appreciation of potential therapeutic effects of R(+)WIN55,212-2 in multiple sclerosis.
|
Authors | Eric J Downer, Eileen Clifford, Sylvie Amu, Padraic G Fallon, Paul N Moynagh |
Journal | The Journal of biological chemistry
(J Biol Chem)
Vol. 287
Issue 30
Pg. 25440-53
(Jul 20 2012)
ISSN: 1083-351X [Electronic] United States |
PMID | 22654113
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics
- Benzoxazines
- Cannabinoids
- GW 6471
- IRF3 protein, human
- Interferon Inducers
- Interferon Regulatory Factor-3
- Irf3 protein, mouse
- Morpholines
- Naphthalenes
- Oxazoles
- PPAR alpha
- Tyrosine
- (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
- Interferon-beta
- Poly I-C
|
Topics |
- Analgesics
(pharmacology)
- Animals
- Benzoxazines
(pharmacology)
- Cannabinoids
(pharmacology)
- Encephalomyelitis, Autoimmune, Experimental
(genetics, metabolism)
- Gene Expression Regulation
(drug effects, genetics)
- HEK293 Cells
- Humans
- Interferon Inducers
(pharmacology)
- Interferon Regulatory Factor-3
(genetics, metabolism)
- Interferon-beta
(biosynthesis, genetics)
- Mice
- Morpholines
(pharmacology)
- Naphthalenes
(pharmacology)
- Oxazoles
(pharmacology)
- PPAR alpha
(agonists, genetics, metabolism)
- Poly I-C
(pharmacology)
- Tyrosine
(analogs & derivatives, pharmacology)
|